LyphoMed Inc tentatively agree form joint venture privately-held Novopharm Ltd Canada whereby market other's drug country. LyphoMed sell Novopharm's oral pharmaceutical drug U.S. Novopharm sell Lyphomed's injectable pharmaceutical drug Canada said. The joint venture give LyphoMed entry hospital retail oral pharmaceutical market Novopharm's product line. Novopharm turn strengthen position Canadian hospital market use LyphoMed's injectable products. The product market cephalexin monohydrate market Eli Lilly Co LLY> Keflex product whose patent expires April. Keflex antibiotic current market excess 250 mln dlrs. It Novopharm Canada sell joint venture distribute LyphoMed U.S. said. Reuter 